albuphine vs fentanyl as additive to main drug bupivacaine in spinal anaesthesia.
Phase 2
- Registration Number
- CTRI/2024/01/062089
- Lead Sponsor
- Dr Virendra Nimbalkar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.American society of anaesthesiologist(ASA) status I and II
2.Age 25-65 years
3.both genders.
Exclusion Criteria
1.Patients with contraindication to spinal anaesthesia
2.Pre-existing neurological deficits
3.Patients with history of allergy to study drugs
4.Pregnant patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method